Cell BiologybioRxivPreprint
Angulin-1/LSR inhibition transiently disrupts the blood-tumor barrier to enhance doxil permeability and impair malignant glioma progression
Dominique T. Ferguson, Minhye Kwak, Sanghee Lim…·Sadhana Jackson
The paper investigates how Angubindin-1 disrupts the blood-tumor barrier by targeting Angulin-1/LSR, enhancing drug permeability and reducing glioma progression.
1 citation